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Abstract
Rabensburg virus (RABV), a Flavivirus with ,76% nucleotide and 90% amino acid identity with representative members of
lineage one and two West Nile virus (WNV), previously was isolated from Culex pipiens and Aedes rossicus mosquitoes in the
Czech Republic, and phylogenetic and serologic analyses demonstrated that it was likely a new lineage of WNV. However,
no direct link between RABV and human disease has been definitively established and the extent to which RABV utilizes the
typical WNV transmission cycle is unknown. Herein, we evaluated vector competence and capacity for vertical transmission
(VT) in Cx. pipiens; in vitro growth on avian, mammalian, and mosquito cells; and infectivity and viremia production in birds.
RABV infection and replication only were detected on mosquito cells. Experimentally inoculated birds did not become
infected. Cx. pipiens had poor peroral vector competence and a higher VT rate as compared to US-WNV in Cx. pipiens. As
a result, we postulate that RABV is an intermediate between the mosquito-specific and horizontally transmitted flaviviruses.
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Introduction
West Nile virus (WNV), a member of the Japanese encephalitis
virus (JEV) serogroup of the Flavivirus genus (family Flaviviridae)i s
grouped into two major genetic lineages. Lineage one WNV is
widely distributed, occurring in Africa, Asia, Europe, Australia,
and North and Central America [1]. In addition to causing West
Nile fever in humans, Lineage one WNV is responsible for
infection of the central nervous system in approximately 1% of
cases, and may lead to a range of clinical outcomes including
encephalitis, meningitis, acute flaccid paralysis and death [2].
Lineage one WNV is further divided into three sublineages:
Lineage 1a is the most widely distributed, occurring in Africa,
Europe, and the Americas; lineage 1b, also known as Kunjin virus
occurs in Australia; lineage 1c occurs in India. Lineage two occurs
in sub-Saharan Africa, where it is the cause of West Nile fever,
a generally self-limiting illness that rarely progresses to severe
disease in humans [3], but recently it has appeared in Europe
(Hungary, Austria, Greece), causing avian, equine, and human
outbreaks occasionally with encephalitis and fatalities. Recently,
a third lineage of WNV called Rabensburg virus (RABV;
prototype strain 97–103) has been proposed. RABV was isolated
first from a pool of Culex pipiens mosquitoes in South Moravia,
Czech Republic in September of 1997 [4], again in the same
location in 1999 [5], and more recently in 2007 it was isolated
from a pool of Aedes rossicus [6]. RABV has 75–77% nucleotide
identity and 89–90% amino acid identity with representative
members of lineage one and two WNV [7], but RABV has shown
partial antigenic heterogeneity with the Egyptian Eg101 topotype
strain of WNV, a representative of lineage one WNV [8], in
plaque-reduction cross-neutralization tests using homologous and
heterologous antisera [5]. Charrel et al. (2003) initially defined
membership in the species WNV to be ,21% genetic distance [9],
yet inclusion of RABV along with Russian and Indian strains of
WNV would increase this criterion to over 25% divergence for
some isolates [10], and would expand WNV into five distinct
lineages [10–12].
RABV initially has been classified as a third lineage of WNV on
the basis of genetic distance, but the biologic and antigenic
differences between RABV and the WNV reference strain Eg-101
(lineage one) support the opinion that RABV is a novel Flavivirus
[7,10]. Although, serological evidence of WNV infection in febrile
humans has been obtained in the Czech Republic [13] and this
was concurrent to the initial isolation of RABV, no direct link
between RABV and human disease has ever been established (i.e.,
no human isolate exists). The extent to which RABV utilizes the
typical WNV transmission cycle is unclear. Consequently, in order
to clarify the mechanism by which RABV is maintained in nature
and, in turn, its ecological relationship to prototype WNV, we
evaluated vector competence, both peroral and capacity for
vertical transmission in Cx. pipiens mosquitoes; in vitro growth on
mosquito, avian, and mammalian cell lines; and infectivity and
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suggest that RABV be considered an intermediate between the
mosquito-specific flaviviruses and the horizontally transmitted
flaviviruses in the JEV serogroup based on the genetic and biologic
differences between it and WNV.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory
Animals of the National Institutes of Health. All animals and animal
facilities were under the control of the Wadsworth Center
Veterinary Science Program with oversight from the NYSDOH
Division of Laboratory Operations and the protocol was approved
by the Wadsworth Center Animal Care and Use Committee
(Approval #09-412 and 09-355).
Cells
AfricanGreenmonkeykidneycells(Vero;ATCC#CCL-81)and
baby hamster kidney cells (BHK; ATCC #CCL-10) were grown in
minimal essential medium (MEM, Gibco, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (FBS, Hyclone, Logan, UT),
2 mM L-glutamine, 1.5 g/l sodium bicarbonate, 100 U/ml of
penicillin, and 100 mg/ml of streptomycin. Aedes albopictus mosquito
cells, (C6/36, ATCC #CRL-1660) were maintained in MEM
supplemented with 10% FBS, 2 mM L-glutamine, 1.5 g/l sodium
bicarbonate, 0.1 mM non-essential amino acids, 100 U/ml of
penicillin, and 100 mg/ml of streptomycin. Chicken embryo
fibroblast cells (DF-1, ATCC #CRL-141) were cultured in
Dulbecco’s modified Eagles’ medium (ATCC #30-2002) supple-
mentedwith10%FBS,2 mML-glutamine,100 U/mlofpenicillin,
100 mg/ml of streptomycin. Human embryonic kidney cells
(Hek293;ATCC#CRL-1573)wereculturedinDulbecco’smodified
Eagles’ medium supplemented with 10% FBS, 2 mM L-glutamine,
1.0 mMsodiumpyruvate, and 1.5 g/l sodiumbicarbonate.
Mosquitoes
All mosquitoes used in this study were maintained at the
Arbovirus Laboratories, Wadsworth Center as described pre-
viously [14,15]. Three different strains of Culex pipiens were used in
the studies described: (1) Cx. pipiens (CpUS) mosquitoes originally
collected during 2004 in Pennsylvania (courtesy of Michael
Hutchinson, Pennsylvania State University, USA), that contain
genetic signatures of form pipiens and form molestus. Cx. pipiens
form pipiens are anautogenous bird-dependent feeders and Cx.
pipiens form molestus are autogenous, breed in confined spaces,
and are more likely to bite humans; (2) a pure line of Cx. pipiens
form molestus (CpEU) from Europe (courtesy of Sander Koen-
raadt, Wageningen University, Netherlands), and (3) pure Cx.
pipiens form molestus (CxM) from the United States (courtesy of
Dina Fonseca, Rutgers University, USA). Culex genetics were
verified as described [16,17].
Viruses
RABV isolate 97-103 (GenBank AY765264), originally isolated
from Cx. pipiens in the Czech Republic, was obtained from Zdenek
Hubalek (Institute of Vertebrate Biology, Academy of Sciences,
Brno, Czech Republic). A virus stock was prepared by inoculation
onto a confluent monolayer of C6/36 mosquito cells and a clarified
harvest of the culture medium was collected after four days of
incubation at 28uC. This stock was titered by fluorescent focus
assay (FFA) on C6/36 cells (log10 7.1 fluorescent foci units (FFU)/
ml) [18]. WNV isolate WN02-1956 (GenBank AY590210) was
isolated from the kidney of an American Crow collected in New
York State and isolated on Vero cells, followed by a single round
of amplification on C6/36 cells. The titer by plaque assay on Vero
cells was log108.6 plaque forming units (PFU)/ml.
Identification of Virus Positive Samples
Virus positive experimental samples were confirmed via hemi-
nested reverse transcriptase polymerase chain reaction (hnRT-
PCR). Briefly, RNA was extracted from WNV and RABV using
the MagMax
TM-96 Viral RNA isolation kit (Ambion) according to
the manufacturer’s instructions using a Tecan Freedom EVOH
robotic platform (Tecan, Mannedorf, Switzerland). Primer sets for
hnRT-PCR targeted the NS5 region and were capable of
detecting all members of the Flaviviridae [19]. For the first
amplification, one-step RT-PCR (Qiagen) was conducted to
produce an amplicon followed by hemi-nested amplification using
the Taq PCR Core Kit (Qiagen).
Viral Replication in vitro and Transfection of Hek293 Cells
Six-well plates containing confluent monolayers of DF-1, BHK,
C6/36, Vero, or Hek293 cells were infected with virus (RABV97-
103 or WN02-1956), in triplicate, at an MOI of 0.01 FFU per
well. After one hour of adsorption at 28uC (C6/36), 37uC
(mammalian), or 39uC (DF-1), the inoculum was removed, 3 ml of
maintenance media was added to each well, and the plates were
returned to the appropriate temperatures. Samples, consisting of
50 ml of media, were taken at 0.5–6 days post infection, diluted
1:10 in culture media, and stored at 280uC.
Hek293 cells were transfected by electroporation as described
by [20] with slight modifications. Instead of using RNA transcripts
generated via in vitro transcription for the transfection, RABV
RNA was extracted from infected C6/36 cell supernatant using
the Qiagen RNeasy kit. Hek293 cells were transfected with 9 mg
viral RABV RNA and medium was harvested from the transfected
cells for seven days and subsequently used to infect new C6/36
cells. Cells were observed for cytopathic effect (CPE) and RNA
was isolated from the infected C6/36 cells and used subsequently
in a RT-PCR to verify RABV infection. C6/36 cells were
transfected with 9 mg viral RABV RNA to serve as a positive
technical control.
Vector Competence
Vector competence was evaluated for CpUS, CpEU, and CxM.
Infection, dissemination, and transmission rates were determined
as described previously [21]. Briefly, mosquitoes were exposed to
virus-infected bloodmeals using a Hemotek membrane feeding
apparatus (Discovery Workshops, Accrington, UK). Bloodmeals
consisted of defibrinated chicken blood (Rockland Inc.) and RABV
from frozen stock, yielding a RABV concentration of
6.1 log10FFU/ml or a WNV concentration of 6.1 log10FFU/ml.
Mosquitoes that fed to repletion were separated into 4.0 L cartons
and maintained on 10% sucrose in an environmental chamber at
27u62uC, 70%610% relative humidity, and with a 16 hour
photoperiod. All samples were screened by hnRT-PCR. Dissem-
ination was indicated by virus-positive legs. Transmission was
defined as release of infectious virus with salivary secretions, i.e.,
the ability to infect another host, and was indicated by virus-
positive salivary secretions [14].
Vertical Transmission
ThecapacityforRABVtobeverticallytransmittedinmosquitoes
was assessed for CxM, CpUS, and CpEU. A finely pulled capillary
microinjection needle was used to intrathoracically inject approxi-
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7.1 log10FFU/mlintoseven-toten-day-oldfemaleCpUS,CpEU,and
CxM(n=150).Femaleswereallowedtomateforsevendayspriorto
viral injection. Seven days post injection (PI) mosquitoes were
exposed to an uninfected bloodmeal and allowed to oviposit. Third
and fourth instar larvae were collected in pools of five and stored at
280uC until they were processed and assessed for viral infection via
hnRT-PCR. The original adult, female mosquitoes were given two
additionalbloodmeals14and21dayspostinitialbloodfeeding.This
experiment wasrepeatedtwicewithseparatecohortsofmosquitoes.
Infectivity and Viremia Production in Birds
Adult house sparrows (Passer domesticus) were caught in Albany
County, New York, using mist nets under NYS Department of
Environmental Conservation license no. 1236 and U.S. Fish and
Wildlife permit no. NB035731-0. Birds were transported to the
Arbovirus Laboratories, Wadsworth Center, treated for ectopar-
asites, and quarantined for two weeks. Following quarantine, birds
were tested for antibodies to WNV via indirect enzyme-linked
immunosorbent assay (ELISA) [22]. All seronegative birds then
were moved into the BSL-3 laboratory and held for one week of
acclimation. Six of the eight birds were inoculated with 10
4 PFU
equivalents of RABV in 100 ml animal diluent (AD: 1% heat-
inactivated FBS in Dulbecco’s PBS) by subcutaneous injection in
the cervical region. The two remaining birds were inoculated with
AD alone to serve as experimental controls. Blood samples were
taken from half of the birds 1, 3, 5 d PI and from the other half of
the birds on 2, 4, 6 d PI as described previously [23]. At 21 d PI,
a 0.1 ml blood sample again was taken to measure RABV
antibody status, and birds then were euthanized by overdose of
pentobarbital (15 mg/kg).
Pathogen-free chicken eggs (Gallus gallus) were obtained from
Sunrise Farms (Catskill, NY, USA) and hatched at the Arbovirus
Laboratories. Chickens were separated into two experimental
groups (five/group) and housed in metal cages with individual light
sources and daily fresh food, water, and resting pads. One- to two-
day-old chickens were inoculated subcutaneously with approxi-
mately 10
4 PFU equivalents of RABV (Group 1) or 10
7 PFU
equivalents of RABV (Group 2). Two additional chickens were
inoculated subcutaneously with AD alone to serve as experimental
controls. All three groups were housed separately in adjacent cages
and monitored daily for signs of illness. Chickens were bled from
the brachial vein and 50–100 ml blood was collected by capillary
action in glass capillary tubes on days 1–5 PI, diluted 1:10 in BA-
1, and stored at 280uC until tested. At day 14 PI, blood was
collected to determine antibody status, and chickens were
euthanized by overdose of pentobarbital (15 mg/kg).
Statistical Analysis
Infection, dissemination, and transmission rates were analyzed
using an Exact unconditional test [24]. Vertical transmission rates
were expressed as the maximum likelihood estimation of infection
rates (MLE-IR), which is defined as the infection rate most likely
observed given the testing results and an assumed probabilistic
model (i.e., binomial distribution of infected individuals in
a positive pool) [25].
Results
Viral Replication in vitro and in vivo
To begin to understand which vertebrate hosts maintain RABV
in nature and its ecological relationship to prototype WNV,
growth kinetics of both viruses were assessed on five cell lines: C6/
36 (mosquito), Vero (monkey), hamster (BHK), human (Hek293),
and avian (DF-1). C6/36 cells inoculated with RABV97-103
displayed overt CPE, and viral growth on mosquito cells that were
inoculated with either RABV97-103 or WNV-WN02-1956 did
not differ significantly between the two viruses over the course of
infection (Figure 1A). In contrast, viral growth on vertebrate cell
culture did differ significantly between RABV and WNV, i.e., no
replication of RABV was observed on BHK, DF-1, Hek293, or
Vero cells (see Figure 1B and 1C for representative growth curves).
In contrast, Hek293 cells transfected via electroporation with
RABV RNA did produce infectious virus as confirmed by the fact
that C6/36 cells inoculated with supernatant from RABV RNA-
transfected Hek293 cultures exhibited an overt CPE, whereas C6/
36 cells inoculated with supernatant from mock-transfected
Hek293 cultures appeared normal. Our data thus indicate that
the inability of RABV to replicate in human cells occurs at the
point of entry, as infectious RABV RNA was able to replicate in
human cells following transfection. In addition to in vitro growth
kinetics, infectivity and viremia production were assessed in vivo in
experimentally inoculated birds (house sparrows and chickens).
Viremia was not detected in either house sparrows or chickens
over the course of experimentation, nor was antibody to RABV
detected at 14 d PI (data not shown).
Vector Competence
It is a well-established fact that mosquitoes in the genus Culex are
competent vectors of WNV, and previous work in our laboratory
has demonstrated that our colonized Cx. pipiens (CpUS) are
competent vectors of WNV [14,26]. In contrast, the ability of
RABV to infect, disseminate, and be transmitted by Culex
mosquitoes is unknown; therefore, we assessed vector competence
for RABV in CpEU and CpUS. Mosquitoes that ingested blood
containing RABV were assayed for viral infection, dissemination,
and transmission and both mosquito strains displayed poor peroral
vector competence as compared to the same mosquitoes infected
with WNV-WN02-1956 (Table 1 and 2). At 14 d PI, the
transmission rate in RABV-infected CpEU was 24% and in
RABV-infected CpUS it was 12%. A poor transmission rate (i.e.,
12%) also was observed at 21 d PI in CxM infected with RABV
(data not shown). Additionally, infection, dissemination, and
transmission were assessed in CpUS and CpEU for both RABV
and US-WNV, and there was a significant reduction (Exact
Unconditional Test, p=0.028) in RABV-positive salivary secre-
tions as compared to US-WNV 14 d post blood feeding in CpEU
(Table 1). The same general trend (i.e., a reduced transmission rate
in mosquitoes infected with RABV) was observed for CpUS
infected with US-WNV or RABV but the data were not
statistically significant (Table 2). The low transmission rates
observed in CpUS infected with US-WNV may be related to
bloodmeal titer (10
6 pfu/mL), i.e., mosquito vectors do not
become infected efficiently when WNV bloodmeal titers are
,10
5 pfu/mL, and higher viral titers in the bloodmeal increase
the probability of mosquito infection [27]. Based on these results,
in conjunction with RABV growth kinetics, we postulated that
RABV might be a mosquito-specific virus, and if mosquitoes
poorly transmitted the virus then RABV must be maintained in
nature by some other method, i.e., vertical transmission (VT).
Vertical Transmission
To ascertain if VT could be responsible for the maintenance of
RABV in mosquito populations, we conducted experiments using
CpEU, CpUS, and CxM to determine the capacity of RABV to be
vertically transmitted. Mosquitoes were infected with RABV via
intrathoracic inoculation of virus, because if RABV were
a mosquito-specific virus then, in nature, mosquitoes would never
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virus was allowed to disseminate throughout the mosquito body
cavity. Larvae were collected, screened via hnRT-PCR for RABV
infection, and VT was observed in all three strains of mosquitoes
(Table 3). CpEU had the highest overall MLE-IR of 41.5, followed
by CpUS with 32.6 and CxM with 21.3. VT was observed in two
independent experiments utilizing different cohorts of mosquitoes
for testing for CpUS and CxM and for CpEU, VT was observed in
one out of two replicate experiments.
Sequence Analysis
Cell fusing agent virus (CFAV), Culex flavivirus, and several
other recently discovered members of the genus Flavivirus have no
known vertebrate host and are thought to infect mosquitoes only.
Firth et al. (2010) identified a ,300 codon gene (designated fifo)
conserved throughout the mosquito-specific flaviviruses that
overlaps the NS2A and NS2B coding sequences [28]. We
analyzed the RABV genome to identify whether fifo was present,
because the results from our viral replication, VT, and vector
competence experiments suggested that RABV was a mosquito-
specific virus. However, sequence analysis of the RABV genome
revealed a 45 codon open reading frame (ORF) (designated foo)
that is conserved among the JEV serogroup flaviviruses (e.g.,
Murray Valley encephalitis virus, St. Louis encephalitis virus, WNV)
[29,30]. RABV shares only ,48% nucleotide identity with
representative members of the mosquito-specific flaviviruses (vs.
.70% nucleotide identity with representative members of the
JEV serogroup) suggesting that perhaps RABV is a link between
the mosquito-specific flaviviruses and the JEV complex of viruses.
Further analysis of the RABV genome revealed the absence of an
N-linked glycosylation motif at NS1 site 207. RABV contains N-
linked glycosylation sites at E154, NS1130, and NS1175. WNV
strains may contain either one or no N-linked glycosylation motif
in the E protein (E154), but all WNV strains contain three highly
conserved NS1 sites (NS1130, NS1175, NS1207). In fact, all
members of the JE serogroup, with the exception of JEV contain
all three NS1 glycosylation motifs [31–34].
Discussion
In sum, we postulate that RABV is an intermediate between the
mosquito-specific flaviviruses and the JEV complex of viruses. This
hypothesis is supported by the fact that unpassaged RABV97-103
did not infect mammalian and avian cell culture, house sparrows
or chickens, but the virus efficiently infected mosquito cells. It
should be noted that replication and CPE have been observed on
a clone of standard Vero cells (E6) and Xenopus laevis frog cells
(XTC-2); however, passage via intracranial inoculation of suckling
mice occasionally has been required for growth on Vero E6 cells.
A third isolate (RABV06-222; GenBank:GQ421359) produced
CPE after original inoculation of mosquito suspension on Vero E6
cells [4,6,7]. It also has been shown that RABV exhibited
a considerably lower virulence in suckling mice as compared to
WNV-Eg-101. RABV97-103 killed all suckling mice after in-
tracerebral inoculation, but following intraperitoneal inoculation it
killed only one third of suckling mice and the average survival time
was 11 days. Adult mice survived even when given the virus
intracerebrally [5]. Interestingly, RABV06-222 was found to kill
Figure 1. Rabensburg virus growth on mosquito, human, and avian cells. Data points represent means of three replicates at each time point
+/2 standard deviation. LOD, limit of detection; WNV, West Nile virus strain WN02-1956; RABV, Rabensburg virus strain 97–103; C6/36, Aedes
albopictus cells; Hek293, human kidney cells; DF-1, chicken cells; pfu, plaque forming units. A.) Mosquito Cells. B.) Human Cells. C.) Avian Cells.
doi:10.1371/journal.pone.0039387.g001
Table 1. Vector competence of European-Culex pipiens form
molestus following peroral infection.*
Days post-feeding
Virus 71 4
ID T ID T
RABV 48 (n=40) 37 (n=19) 0 74 (n=34) 96 (n=25) 24 (n=25)
WN02-1956 ND ND ND 62 (n=34) 100(n=21)57 (n=21)
p value
{ ND ND ND 0.366 1.00 0.028
*I, % infected; D, % disseminated (of infected); T, % transmitting (of infected);
ND, no data.
{Calculated using an exact unconditional test.
doi:10.1371/journal.pone.0039387.t001




ID T ID T
RABV 43 (n=40) 47 (n=17) 6 (n=17) 65 (n=40) 42 (n=26) 12 (n=26)
WN02-1956 30 (n=40) 42 (n=12) 17 (n=12) 55 (n=40) 41 (n=22) 18 (n=22)
p value
{ 0.272 1.00 0.500 0.434 1.00 1.00
*I, % infected; D, % disseminated (of infected); T, % transmitting (of infected).
{Calculated using an exact unconditional test.
doi:10.1371/journal.pone.0039387.t002
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administration [6].
In addition, mosquitoes within the Culex pipiens complex
supported replication of RABV but displayed poor peroral
vector competence for this virus as compared to WNV-WN02-
1956, and the same mosquitoes vertically transmitted the virus
at a much higher rate than what has been reported for wild
type WNV in US-Cx. pipiens. In 2002, Dohm et al. demon-
strated that U.S.-Cx. pipiens could vertically transmit WNV,
albeit at a much lower rate than what was observed in this
study, i.e., they calculated an overall minimal filial infection rate
of 1.8/1000 (or an approximated MLE-IR of 1.86) [35] versus
the calculated overall MLE-IR of 32.6 in our CpUS, 21.3 in
CxM, and 41.5 in CpEU. We also have observed VT of wild
type WNV in CpUS at a MLE-IR of 2.9 following an infectious
bloodmeal (Aliota et al., unpublished). In addition, Turell et al.
(2001) demonstrated VT of WNV in laboratory Cx. pipiens [36],
and Miller et al. (2000) identified male, WNV-infected Culex
univittatus in Kenya [37] indicating that VT of WNV does occur
in nature and probably is responsible for seasonal maintenance
of the virus in more temperate regions [38].
The ‘‘intermediate’’ hypothesis is supported further by the fact
that it recently has been shown that the filial infection rate of
vertically transmitted Culex flavivirus, a virus that only infects
mosquitoes, was 97.4% [39], and by the fact that Aedes albopictus
exposed to a CFAV-infected bloodmeal did not become infected
with CFAV (Aliota et al., unpublished). Clearly, some of our
mosquitoes were capable of transmitting RABV, and it has not yet
been excluded that RABV might circulate and be amplified in
certain vertebrates, e.g., amphibians [4,6,7]. Additionally, se-
quence analysis of the RABV genome revealed the presence of an
ORF that is conserved among the JEV complex of viruses, and it
revealed the absence of an N-linked glycosylation motif at NS1 site
207. This was interesting because WNV strains may contain either
one or no N-linked glycosylation motif in the E protein (E154), but
all WNV strains contain three highly conserved NS1 sites (NS1130,
NS1175, NS1207). In fact, all members of the JE serogroup, with the
exception of JEV contain all three glycosylation motifs [31–34]. N-
linked glycosylation plays an important role in both the assembly
and the infectivity of many viruses (e.g., [40–43]). Studies have
demonstrated that non-glycosylated NS1 can influence neuroinva-
siveness and impair replication for dengue and yellow fever, and
deglycosylation of both E and NS1 proteins of WNV completely
attenuated neuroinvasiveness and induced protective immunity in
the murine model with low doses of virus [44].
The majority of previous studies on flavivirus evolution have
suggested that arthropod-mediated transmission is a derived trait
within the genus, with the ancestral condition being non-vector
transmission [45]. Therefore, it would be appropriate to assume
that at least some of the current group of horizontally transmitted
flaviviruses evolved from mosquito-specific viruses. Recently, there
has been an upsurge in the discovery of ‘insect-specific’ flaviviruses
and/or their related sequences in natural mosquito populations
[46]. And considering the high genetic plasticity associated with
flaviviruses, it is reasonable to assume that some of these mosquito-
specific viruses may emerge and adapt to new host environments,
i.e., humans or other vertebrates. Timely recognition of emerging
infections depends on an understanding of all of the factors
involved in the maintenance and spread of an infectious organism.
Future studies utilizing RABV could provide significant insight
into the determinants of flavivirus attenuation in vertebrates and
vertical transmission in mosquitoes. Specifically, RABV could be
used to elucidate genetic changes that facilitate host switching,
which may lead to new vertebrate pathogens or new transmission
pathways. Additionally, it could increase our understanding of the
link between the ‘insect-specific’ flaviviruses and those that are
transmitted between mosquitoes and vertebrates, further clarifying
the evolution of flaviviruses.
Table 3. Vertical transmission of Rabensburg virus in three strains of Culex pipiens.*
Mosquito Strain Oviposition dpi No. of pools tested
{ MLE [positive pools/total]
CpUS
OP1 Larvae 7 151 46.5 [32/151]
OP2 Larvae 14 69 15.0 [5/69]
OP3 Larvae 21 22 0.00 [0/22]
MLE Combined 32.6 [37/242]
CpEU
OP1 Larvae 7 43 40.3 [8/43]
OP2 Larvae 14 23 47.8 [5/23]
OP3 Larvae 21 2 0.00 [0/2]
MLE Combined 41.5 [13/68]
CxM
OP1 Larvae 7 35 5.78 [1/35]
OP2 Larvae 14 9 49.0 [2/9]
OP3 Larvae 21 5 97.1 [2/5]
MLE Combined 21.3 [5/49]
*MLE, maximum likelihood estimation of infection rates; CpUS, a United States strain of Culex pipiens that contain genetic signatures of both form pipiens and form
molestus; CpEU, a European strain of Culex pipiens form molestus; CxM, a United States strain of Culex pipiens form molestus; OP, oviposition; dpi, days post infection;
Vertical transmission of RABV was observed in two independent experiments for CpUS and CxM and in one out of two independent replicates for CpEU. All surviving
parental females were pooled in groups of five, screened for viral infection, and all pools were RABV positive.
{pool size=5.
doi:10.1371/journal.pone.0039387.t003
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